Cargando…
Clinical implication of low estrogen receptor (ER-low) expression in breast cancer
Breast cancer is a heterogeneous disease, and the estrogen receptor (ER) remains the most important biomarker in breast oncology. Most guidelines set a positive expression threshold of 1% staining in immunohistochemistry (IHC) to define ER positivity. However, different expression levels may be asso...
Autores principales: | Reinert, Tomás, Cascelli, Fanny, de Resende, Cristiano Augusto Andrade, Gonçalves, Aline Coelho, Godo, Vania Sanchez Prette, Barrios, Carlos Henrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729538/ https://www.ncbi.nlm.nih.gov/pubmed/36506043 http://dx.doi.org/10.3389/fendo.2022.1015388 |
Ejemplares similares
-
Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019) -
Association of ESR1 Mutations and Visceral Metastasis in Patients with Estrogen Receptor-Positive Advanced Breast Cancer from Brazil
por: Reinert, Tomás, et al.
Publicado: (2019) -
Epigenetic changes in the estrogen receptor α gene promoter: implications in sociosexual behaviors
por: Matsuda, Ken Ichi
Publicado: (2014) -
Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer
por: Tecalco-Cruz, Angeles C., et al.
Publicado: (2022) -
SCM-198 Prevents Endometriosis by Reversing Low Autophagy of Endometrial Stromal Cell via Balancing ERα and PR Signals
por: Lin, Yi-Kong, et al.
Publicado: (2022)